Antibiotic resistance of the main uropathogens in patients with acute secondary pyelonephritis
- Autores: Antonov A.G.1, Mikhailichenko A.O.1, Svishcheva E.V.2, Taran E.K.3
-
Afiliações:
- FSBEI HE «Far Eastern State Medical University» of the Ministry of Health of Russia
- Federal Center for Cardiovascular Surgery of the Ministry of Health of Russia
- Regional Clinical Hospital named after Professor S.I. Sergeev of the Ministry of Health of the Khabarovsk Territory
- Edição: Nº 5 (2025)
- Páginas: 18-23
- Seção: Original Articles
- ##submission.datePublished##: 18.11.2025
- URL: https://journals.eco-vector.com/1728-2985/article/view/696330
- DOI: https://doi.org/10.18565/urology.2025.5.18-23
- ID: 696330
Citar
Texto integral
Resumo
Relevance. Pyelonephritis is an infectious and inflammatory disease of the kidneys with predominant damage to the mucous membrane of the pelvis and calyces and/or interstitial tissue. In complicated acute pyelonephritis, the frequency of E. coli isolation is 63,3%. Less common pathogens are Proteus mirabilis (6,1%), Pseudomonas aeruginosa (1,3%), Klebsiella pneumoniae (13,5%). Enterobacteriaceae are characterized by high levels of resistance to many antimicrobial drugs (AMPs). Today, the greatest clinical significance is the increase in resistance of enterobacteria strains to modern cephalosporins and carbapenems.
Purpose of the study. To study the level of resistance of pyelonephritis pathogens to antibacterial drugs of various groups, to identify producers of extended spectrum beta-lactamases and carbapenemases among the causative agents of acute secondary pyelonephritis.
Materials and methods. The medical histories of 305 medical histories of patients who were undergoing inpatient treatment at the uronephrological center of the Regional Clinical Hospital named after Professor S.I. Sergeev, Khabarovsk with an established diagnosis: acute secondary pyelonephritis. The material for laboratory research was the average portion of freely released urine obtained after toileting the genital organs, or urine collected by a catheter using a generally accepted method. Identification of microorganisms was carried out using automatic bacteriological analyzers. Antimicrobial susceptibility was tested using the disk diffusion method. Molecular genetic analysis was carried out using the PCR method.
Results and discussion. The resistance of microorganisms that cause acute secondary pyelonephritis to antibacterial drugs of various groups was assessed. The mechanisms of antibiotic resistance of enterobacteriaceae have been studied. A high prevalence of extended spectrum beta-lactamase producers was revealed. In E. coli isolates. genes of the bla CTX-M-1 cluster predominated (34%). Carbopenemase production was detected in 24% of the analyzed E.coli strains. The vast majority of K. pneumoniae strains produced extended-spectrum beta-lactamases of the bla SHV cluster (87.5%). The frequency of carbapenemase production among K. pneumoniae isolates was 68.7%.
Conclusion. If acute secondary pyelonephritis is suspected and empirical therapy is prescribed, assessment of the local resistance phenotype of the leading pathogens is necessary to exclude from the selection of antibacterial agents to which there is a high level of resistance.
Texto integral
Sobre autores
Alexander Antonov
FSBEI HE «Far Eastern State Medical University» of the Ministry of Health of Russia
Email: antonovs@rambler.ru
Dr.Sc. professor. Head of the Department of Urology and Nephrology
Rússia, KhabarovskAlexander Mikhailichenko
FSBEI HE «Far Eastern State Medical University» of the Ministry of Health of Russia
Autor responsável pela correspondência
Email: mao4212@mail.ru
Assistant Professor, Department of Urology and Nephrology
Rússia, KhabarovskEkaterina Svishcheva
Federal Center for Cardiovascular Surgery of the Ministry of Health of Russia
Email: e.svishcheva@mail.cardiokhv.ru
Head of Bacteriological Laboratory
Rússia, KhabarovskEkaterina Taran
Regional Clinical Hospital named after Professor S.I. Sergeev of the Ministry of Health of the Khabarovsk Territory
Email: direct@kkb1.medkhv.ru
Head of Bacteriological Laboratory
Rússia, KhabarovskBibliografia
- Perepanova T.S., Kozlov R.S., Rudnov V.A., Sinyakova L.A., Palagin I.S. Federal Clinical Guidelines «Antimicrobial Therapy and Prevention of Infections of the Kidneys, Urinary Tract, and Male Genital Organs. Uromedia Publishing House, Moscow, 2022, 126 p. Russian (Перепанова Т.С., Козлов Р.С., Руднов В.А., Синякова Л.А., Палагин И.С. Федеральные клинические рекомендации «Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Издательский дом «Уромедиа», М., 2022, 126 с.)
- Bonkat G., Bartoletti R., Bruyere F., Cai T., Geerlings S.E., Köves B. et al. EAU Urological Infections Guidelines. Edn. Presented at the EAU Annual Congress Milan Italy. 2021 ISBN 978-94-92671-13-4.
- Bochkarev A.B, Kostuykov S.V., Shamatrina E.I., Merinov D.S. Antibiotic resistance in urological patients with inflammatory diseases of the upper urinary tract. Experimental and Clinical Urology. 2019;2:106–110. https://doi.org/ 10.29188/2222-8543-2019-11-2-106-110. Russian (Бочкарев А.Ю., Костюков С.В., Шаматрина Е.И., Меринов Д.С. Антибиотикорезистентность у урологических пациентов с воспалительными заболеваниями верхних мочевыводящих путей. Экспериментальная и клиническая урология. 2019;2:106–110).
- Kozlov R.S., Palagin I.S., Ivanchik N.V., Trushin I.V., Dekhnich A.V., Eidelstein M.V., Perepanova T.S, and «DARMIS-2023» Study Group. National monitoring of antibiotic resistance of pathogens causingcommunity-acquired urinary tract infections in Russia: results of the multicenter epidemiological study «DARMIS-2023». Klinicheskaya mikrobiologiya i antimikrobnaya himioterapiya = Clinical Microbiology and Antimicrobial Chemotherapy 2024;26(3):328-337. https://doi.org/ 10.36488/cmac.2024.3.328-337. Russian (Козлов Р.С., Палагин И.С., Иванчик Н.В., Трушин И.В., Дехнич А.В., Эйдельштейн М.В., Перепанова Т.С. и исследовательская группа «ДАРМИС-2023». Национальный мониторинг антибиотикорезистентности возбудителей внебольничных инфекций мочевых путей в России: результаты многоцентрового эпидемиологического исследования «ДАРМИС-2023». Клин. микробиология антимикробная химиотерапия. – 2024. – Т. 26. – № 3. С.328– 337).
- Wagenlehner F.M.E. Neue Antibiotika in der Behandlung von Harnwegsinfektionen [New antibiotics for the treatment of urinary tract infections]. Urologie. 2023;62(7):705–710. https://doi.org/10.1007/s00120-023-02121-5.
- Murray C.J.L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 2022;399(10325):629–655. https://doi.org/10.1016/S0140-6736(21)02724-0.
- Medina-Polo J., Naber K.G., Bjerklund Johansen T.E. Healthcareassociated urinary tract infections in urology. GMS Infect Dis. 2021;9. ID Doc05. https://doi.org/10.3205/id000074.
- Sukhorukova M.V., Edelstein M.V., Ivanchik N.V., Skleenova E.Yu., Shajdullina E.R., Azyzov I.S. et al. Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study «MARATHON 2015–2016». 2019;21(2):147–159. https://doi.org/10.36488/cmac.2019.2.147-159. Russian (Сухорукова М.В., Эйдельштейн М.В., Иванчик Н.В., Склеенова Е.Ю., Шайдуллина Э.Р., Азизов И.С. и соавт. Антибиотикорезистентность нозокомиальных штаммов Enterobacteriaceae в стационарах России: результаты многоцентрового эпидемиологического исследования МАРАФОН в 2015–2016 гг. Клиническая микробиология и антимикробная химиотерапия. 2019;21(2):147-159).
- Palagin I.S. Sukhorukova M.V., Dekhnich A.V., Edelstein M.V., Shevelev A.V., Grinev A.V., Perepanova T.S., Kozlov R.S., DARMIS Study Group. Current state of antibiotic resistance of pathogens causing community-aquired urinary tract infections in Russia: «DARMIS» Study (2010–2011). KMAKH 2012;14(4):280–302. Russian (Палагин И.С., Сухорукова М.В., Дехнич А.В., Эйдельштейн М.В., Шевелев А.Н., Гринев А.В., Перепанова Т.С., Козлов Р.С. Исследовательская группа «ДАРМИС». Современное состояние антибиотикорезистентности возбудителей внебольничных инфекций мочевых путей в России: результаты исследования «ДАРМИС» (2010–2011). Клиническая микробиология и антимикробная химиотерапия. 2012;14(4):280–302).
- Tilahun M., Kassa Y., Gedefie A., Ashagire M. Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review. Infect Drug Resist. 2021 Oct 21;14:4363-4374. https://doi.org/10.2147/IDR.S337611.
- Sinyakova L.A., Kosova I.V., Nezovibatko Y.I. Treatment of lower urinary tract infections in women. Meditsinsky Sovet. 2018;21:184–191. https://doi.org/10.21518/2079-701X-2018-21-184-191. Russian (Синякова Л.А., Косова И.В., Незовибатько Я.И. Лечение инфекций нижних мочевых путей у женщин. Медицинский совет. 2018;21:184–191).
- Vinogradova A.G., Kuzmenkov A.Yu. Practical application of AMRmap: elements of the «from General to particular» approach on the example of Klebsiella pneumoniae. Klinicheskaya mikrobiologiya i antimikrobnaya himioterapiya = Clinical Microbiology and Antimicrobial Chemotherapy 2019;21(2):181–186. https://doi.org/10.36488/cmac.2019.2.181-186. Russian (Виноградова А.Г., Кузьменков А.Ю. Практическое применение AMRmap: элементы подхода «от общего к частному» на примере Klebsiella pneumoniae. Клиническая микробиология и антимикробная химиотерапия. 2019;21(2):181–186).
- Leski T.A., Bangura U., Jimmy D.H., Ansumana R., Lizewski S.E., Li R.W., Stenger D.A., Taitt C.R., Vora G.J. Identification of blaOXA-₅₁-like, blaOXA-₅₈, blaDIM-₁, and blaVIM carbapenemase genes in hospital Enterobacteriaceae isolates from Sierra Leone. J Clin Microbiol. 2013;51(7):2435–38. https://doi.org/10.1128/JCM.00832-13.
Arquivos suplementares


